Camber Capital Management’s Atara Biotherapeutics ATRA Stock Holding History

Camber Capital Management’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-56,000	Closed	-$18.1M	–	33
2020 Q3	$18.1M	Hold	56,000	–	–	0.96%	27
2020 Q2	$20.4M	Sell	56,000 -3,150	-5%	-$796K	1.17%	23
2020 Q1	$12.6M	Sell	59,150 -58,850	-50%	-$18.7M	0.75%	25
2019 Q4	$48.6M	Hold	118,000	–	–	2.47%	20
2019 Q3	$41.7M	Buy	118,000 +38,000	+48%	+$14.2M	2.19%	20
2019 Q2	$40.2M	Hold	80,000	–	–	1.87%	22
2019 Q1	$79.5M	Buy	80,000 +4,000	+5%	+$3.72M	3.96%	10
2018 Q4	$66M	Buy	76,000 +11,200	+17%	+$10.4M	3.13%	12
2018 Q3	$67M	Hold	64,800	–	–	2.87%	13
2018 Q2	$59.5M	Buy	64,800 +132	+0.2%	+$142K	2.29%	20
2018 Q1	$63.1M	Buy	64,668 +43,248	+202%	+$39.4M	3.1%	13
2017 Q4	$9.69M	Hold	21,420	–	–	0.47%	29
2017 Q3	$8.86M	Hold	21,420	–	–	0.56%	22
2017 Q2	$7.5M	Buy	21,420 +16,420	+328%	+$6.33M	0.37%	31
2017 Q1	$2.57M	Buy	+5,000	New	+$2.07M	0.1%	30

Other funds holding ATRA

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return